US20140364806A1 - Rapid fluid cooling devices and methods for cooling fluids - Google Patents

Rapid fluid cooling devices and methods for cooling fluids Download PDF

Info

Publication number
US20140364806A1
US20140364806A1 US14/452,642 US201414452642A US2014364806A1 US 20140364806 A1 US20140364806 A1 US 20140364806A1 US 201414452642 A US201414452642 A US 201414452642A US 2014364806 A1 US2014364806 A1 US 2014364806A1
Authority
US
United States
Prior art keywords
target fluid
reactant
endothermic
cooling device
inlet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/452,642
Inventor
Andrew J. Dimeo
Nathan M. Cox
Steven P. Grove
Samuel Lee
Luke D. Oltmans
Kathryn H. Sauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Carolina State University
Original Assignee
North Carolina State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Carolina State University filed Critical North Carolina State University
Priority to US14/452,642 priority Critical patent/US20140364806A1/en
Publication of US20140364806A1 publication Critical patent/US20140364806A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/0085Devices for generating hot or cold treatment fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/44Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00Local anaesthesia; Hypothermia
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25DREFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
    • F25D5/00Devices using endothermic chemical reactions, e.g. using frigorific mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • A61F2007/0268Compresses or poultices for effecting heating or cooling having a plurality of compartments being filled with a heat carrier
    • A61F2007/0276Compresses or poultices for effecting heating or cooling having a plurality of compartments being filled with a heat carrier with separate compartments connectable by rupturing a wall or membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/10Cooling bags, e.g. ice-bags
    • A61F7/106Cooling bags, e.g. ice-bags self-cooling, e.g. using a chemical reaction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/36General characteristics of the apparatus related to heating or cooling
    • A61M2205/3606General characteristics of the apparatus related to heating or cooling cooled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/36General characteristics of the apparatus related to heating or cooling
    • A61M2205/364General characteristics of the apparatus related to heating or cooling by chemical reaction

Definitions

  • the present invention relates generally to fluid cooling devices. More particularly, the present invention relates to the cooling of fluids by endothermic reaction.
  • the cooling of core body temperature is a medical treatment increasingly being used to treat patients as part of various medical-related procedures.
  • Administering cooled intravenous fluids to induce hypothermia in cardiac arrest patients in the pre-hospital setting has been found to improve the likelihood of those patients being subsequently discharged from the hospital neurologically intact.
  • Induced hypothermia therapy has proven effective in postponing damage to tissues caused by insufficient blood flow and oxygen deprivation. The smaller the time difference between cardiac arrest and induced hypothermia, the higher the likelihood of successful treatment. While there are in-hospital products available for inducing hypothermia, these products are not feasible for use in the pre-hospital setting.
  • the present disclosure provides methods, processes, systems, apparatus, instruments, and/or devices, as described by way of example in implementations set forth below.
  • a cooling device includes a target fluid inlet, a target fluid outlet, an inner conduit, and a chamber surrounding the inner conduit.
  • the inner conduit fluidly communicates with the target fluid inlet and the target fluid outlet, and provides a flow path for a target fluid to be cooled.
  • the chamber surrounding the inner conduit contains a first endothermic reactant and includes a reactant inlet selectively alterable from a closed state to an open state. When the reactant inlet is in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs.
  • the reactant inlet When the reactant inlet is in the open state, the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and cooling the target fluid in the inner conduit.
  • the reactant inlet of the cooling device may further include a barrier.
  • the barrier When the reactant inlet is in the closed state, the barrier may divide the chamber into a first region containing the first endothermic reactant, and a second region containing the second endothermic reactant.
  • the cooling device may include an actuator configured to open the barrier wherein the reactant inlet is altered to the open state.
  • the cooling device includes a pressure release valve adapted to communicate with the chamber, wherein the pressure release valve allows flow from the chamber to a receptacle adapted to communicate with the pressure release valve when the pressure in the chamber increases to a predetermined critical pressure.
  • At least a portion of the chamber is flexible such that the volume of the chamber is expandable.
  • the cooling device includes an insulating material surrounding the chamber.
  • the target fluid includes saline solution.
  • the target fluid further includes a therapeutically active drug.
  • the reactant inlet comprises a fitting configured for connection to an external source of the second endothermic reactant.
  • the reactant inlet comprises a valve.
  • an intravenous target fluid delivery system includes an IV target fluid reservoir, a cooling device, and a cooled IV target fluid receiving tube.
  • the IV target fluid reservoir contains an IV target fluid to be cooled in the cooling device.
  • the IV target fluid reservoir fluidly communicates with a target fluid inlet of the cooling device.
  • the cooled IV target fluid receiving tube fluidly communicates with a target fluid outlet of the cooling device, and is configured for intravenously administering the cooled IV target fluid to a patient.
  • the first endothermic reactant includes an inorganic salt such as, for example, ammonium nitrate, ammonium chloride, potassium chloride, etc.
  • the second endothermic reactant may, for example, include water.
  • the reactant inlet includes a barrier and in the closed state, the barrier divides the chamber into a first region containing the first endothermic reactant, and a second region containing the second endothermic reactant.
  • an actuator is configured to open the barrier wherein the reactant inlet is altered to an open state.
  • the actuator may be configured to puncture the barrier.
  • the actuator may be configured to move at least a portion of the barrier to create an opening therethrough.
  • the IV target fluid reservoir may include an IV bag.
  • the cooled IV target fluid receiving tube may include an IV catheter.
  • a method for cooling a target fluid.
  • a target fluid is flowed from a target fluid inlet of a cooling device, through the cooling device, and to a target fluid outlet of the cooling device. While flowing the target fluid, heat is removed from the target fluid by conducting an endothermic reaction in the cooling device.
  • a method for treating a patient.
  • a target fluid to be cooled is flowed from a reservoir through a target fluid inlet of a cooling device, and into an inner conduit of the cooling device.
  • the cooling device includes a chamber surrounding the inner conduit and containing a first endothermic reactant.
  • the chamber includes a reactant inlet selectively alterable from a closed state to an open state, wherein in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs.
  • the endothermic reaction is initiated and the target fluid in the inner conduit is cooled by altering the reactant inlet from the closed state to the open state, wherein the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber.
  • the cooled target fluid is flowed through a target fluid outlet of the cooling device into a cooled-fluid-receiving tube.
  • the cooled target fluid is administered to the patient intravenously to reduce the patient's core body temperature.
  • the target fluid includes saline solution. In further implementations, the target fluid further comprises a therapeutically active drug.
  • FIG. 1 is a simplified perspective view of an example of a fluid cooling device according to the present teachings.
  • FIG. 2 is an exploded perspective view of an example of a fluid cooling device according to the present teachings.
  • FIG. 3 is a cut-away view of a portion of a chamber surrounding inner helical conduits according to the present teachings.
  • FIG. 4 is a cross-sectional elevation view of another example of a fluid cooling device according to the present teachings that illustrates a barrier within the chamber.
  • FIG. 5 is a flow diagram illustrating a method for cooling a target fluid according to the present teachings.
  • FIG. 6 is a flow diagram illustrating a method for treating a patient according to the present teachings.
  • FIG. 7 is a schematic of an intravenous target fluid delivery system according to the present teachings.
  • FIGS. 1-7 illustrate various implementations of a fluid cooling device, a method for cooling a target fluid, a method for treating a patient, and a related system.
  • the various implementations provide a highly effective, compact, transportable, and efficient solution for rapidly cooling a target fluid for use, as for example, in the pre-hospital setting for intravenously inducing hypothermia or otherwise significantly reducing the core body temperature in cardiac arrest patients as well as for other medical uses and non-medical uses.
  • the less the difference in time between cardiac arrest and induced hypothermia the higher the likelihood of success in subsequently discharging cardiac arrest patients from the hospital neurologically intact.
  • Hypothermia is defined as a body temperature significantly below 37° C., and there are various levels of hypothermia. For example, mild hypothermia is defined as a body temperature of about 34° C., moderate hypothermia is defined as a body temperature of about 23-32° C. and profound hypothermia is defined as a body temperature of about 12-20° C. See Stedman's Medical Dictionary, 26 th Edition, 1995.
  • a fluid cooling device consistent with the present teachings has experimentally demonstrated superior performance in providing a cooled target fluid for use in the pre-hospital setting, as compared with the current method of cooling fluids in the pre-hospital setting via conventional refrigeration.
  • a fluid cooling device has experimentally cooled a target fluid (i.e., saline solution) from room temperature to about 4° C. in about 1.5 to 2.0 minutes, wherein ammonium nitrate and water were utilized as the endothermic reactants in the cooling device.
  • the cooling device according to the present teachings may be sized and configured for compatibility with associated fluid delivery components.
  • the cooling device may be easily connected to standardized intravenous delivery equipment to function as an in-line, on-demand chilling device. All or part of the cooling device may be sterilizable and reusable, or alternatively may be configured as a disposable single-use device.
  • FIG. 1 is a simplified perspective view of an example of a fluid cooling device 100 according to the present teachings.
  • the cooling device 100 generally includes a target fluid inlet 102 through which a target fluid (e.g., saline solution) to be cooled may enter the cooling device 100 , and a target fluid outlet 104 through which the target fluid may exit the cooling device 100 .
  • the cooling device 100 also generally includes a chamber 106 surrounding one or more inner conduits (not shown in FIG. 1 ) between the target fluid inlet 102 and the target fluid outlet 104 , and containing a first endothermic reactant (e.g., ammonium nitrate, ammonium chloride, potassium chloride, or the like).
  • a first endothermic reactant e.g., ammonium nitrate, ammonium chloride, potassium chloride, or the like.
  • the first endothermic reactant may, for example, be packed into the chamber 106 in any suitable form such as powder, pellets, grains, gel, colloid, suspension, liquid, or the like, and may fill the volume in the chamber 106 around the inner conduit or conduits.
  • the inner conduit fluidly communicates with the target fluid inlet 102 and the target fluid outlet 104 , and provides one or more flow paths for a target fluid to be cooled.
  • An example of an inner conduit provided as one or more inner helical conduits is described below with respect to FIGS. 2 and 3 .
  • the inner conduit(s) may be constructed of various materials (e.g., medical grade metals, thermally conductive plastics, and the like) and may include various shapes and cross-sectional areas so as to optimize the available surface area for heat transfer.
  • the target fluid inlet 102 may generally be configured to accommodate the size of any inlet tubing or fitting connected to the target fluid inlet 102 .
  • the target fluid outlet 104 may generally be configured to accommodate the size of any outlet tubing or fitting connected to the target fluid outlet 104 .
  • the chamber 106 also generally includes a reactant inlet 108 that is selectively alterable from a closed state to an open state.
  • the reactant inlet 108 may include, for example, a Luer-LockTM port or any valve or fitting switchable between closed and open states, or an openable or frangible barrier.
  • the first endothermic reactant In the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs.
  • the reactant inlet 108 In the open state, the reactant inlet 108 provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber 106 for initiating the endothermic reaction and consequently cooling the target fluid in the inner conduit.
  • the second endothermic reactant may be provided in any suitable form (e.g., solid, semi-solid, colloidal, liquid, etc.).
  • the first and/or second endothermic reactant may include any suitable additive that promotes or optimizes the endothermic reaction.
  • the specific reactants utilized in the cooling device 100 will depend on the particular endothermic reaction being implemented.
  • ammonium nitrate, ammonium chloride, or potassium chloride may be utilized as the first endothermic reactant, and in each case, water may be utilized as the flowable second endothermic reactant.
  • Other flowable materials may also be suitable for serving as the second endothermic reactant.
  • the cooling device 100 may employ any combination of reactants that, when combined, result in an endothermic reaction suitable for rapid cooling of a selected target fluid such as, for example, saline solution.
  • the second endothermic reactant may be flowed into the chamber 106 via the reactant inlet 108 by any suitable means such as, for example, utilizing a syringe (not shown) or other external source of reactant.
  • the second endothermic reactant may be provided internally within the cooling device as described by example below in conjunction with FIG. 4 .
  • the first endothermic reactant may not be pre-loaded in the chamber 106 .
  • both the first and second endothermic reactants may be supplied from external sources (e.g., syringes) into the chamber 106 via the reactant inlet 108 in any order (or from two separate reactant inlets) for initiating the endothermic reaction.
  • Having the first endothermic reactant and/or the second endothermic reactant preloaded in the chamber 106 may be particularly useful in implementations in which the cooling device 100 is utilized to rapidly cool intravenous fluids in the pre-hospital setting, for example.
  • the chamber 106 may be constructed of, for example, PVC plastic.
  • an end plate 110 may be attached to the chamber 106 by any suitable means, and may be constructed to accommodate the ends of the inner conduits.
  • An end cap 112 may also be secured by any suitable means to the end plate 110 and/or chamber 106 at each end of the chamber 106 .
  • the end caps 112 may be tapered or otherwise configured to accommodate the positions of the inner conduit(s) and/or the flow transitions between the inner conduit(s) of the chamber 106 and the target fluid inlet 102 and target fluid outlet 104 .
  • Both the end plates 110 and the end caps 112 may be constructed of, for example, ABS plastic.
  • a pressure release valve 114 may optionally be provided to communicate with the chamber 106 such that pressure may release from the chamber 106 to, for example, a receptacle (not shown) adapted to communicate with the pressure release valve 114 when the pressure in the chamber 106 increases to a predetermined critical pressure. For example, if a syringe is used to admit the second endothermic reactant into the chamber 106 via the reactant inlet 108 , the pressure release valve 114 may be used to release any excess pressure in the chamber 106 resulting from utilization of the syringe. The use of a receptacle at the pressure release valve 114 maintains the cooling device 100 as a closed system and ensures that the endothermic reactants remain isolated from the environment.
  • element 114 may represent a fluid connection to a flexible chamber that allows for expansion.
  • at least a portion of the chamber 106 may be flexible to allow for expansion.
  • the chamber 106 may also be surrounded by an insulating material (e.g., polypropylene foam covered in vinyl fabric) to ensure a minimum amount of heat transfer into the cooling device 100 from the outside environment.
  • the cooling device 100 in FIG. 1 may be used to rapidly, effectively and reliably supply cooled fluids in a manner which does not require the aid of any other device.
  • the cooling device 100 may be utilized to quickly supply cooled saline solution for intravenous administration to cardiac arrest patients in the pre-hospital setting, so as to reduce the core body temperature of the patients.
  • the cooling device 100 is completely isolated from the external environment, ensuring no contamination of the target liquid, any potential user, and any potential patient while the cooling device 100 is in use.
  • the cooling device 100 may also be utilized in various other settings, e.g., stroke therapy and cardiac surgery.
  • the cooling device 100 may be utilized in a wide variety of non-medical as well as medical applications for cooling various liquids, gases, vapors, suspensions, etc.
  • the cooling device 100 may be portable, easily storable and easily disposed of after use.
  • the cooling device 100 may be easily connected to input tubing and output tubing for use as an in-line device, as described in further detail below with respect to FIG. 7 .
  • the cooling device 100 according to the present teachings may be manufactured in varying sizes and dimensions so as to allow for various temperatures of the target fluid at the target fluid outlet 104 of the cooling device 100 . For example, reducing the length of the cooling device 100 may result in a higher temperature of the target fluid at the target fluid outlet 104 as a result of a decrease in surface area utilized for heat transfer.
  • the cooling device 100 may be manufactured with varying amounts of the first endothermic reactant so as to allow for various temperatures of the target fluid at the target fluid outlet 104 of the cooling device 100 .
  • different cooling devices 100 according to the present teachings may be manufactured with different endothermic reactants so as to allow for various temperatures of the target fluid at the target fluid outlet 104 of the cooling devices 100 .
  • a target fluid flowing through the cooling device 100 may be cooled from room temperature down to about 3 or 4° C. upon exit from the cooling device 100 .
  • the time required for this amount of cooling to occur from the target fluid inlet 102 to the target fluid outlet 104 will depend on a variety of factors, including for example the volume of the chamber 106 and of the reactant loaded therein, the internal diameter and length of the inner conduit(s) and thus the resulting flow rate and residence time of the target fluid in the chamber 106 , as well as the specific endothermic reactants utilized.
  • FIG. 2 is an exploded perspective view of an example of the fluid cooling device 100 discussed above.
  • the fluid cooling device 100 may be utilized as described above with respect to FIG. 1 , or as otherwise described in the present teachings.
  • the cooling device 100 also includes the chamber 106 containing the first endothermic reactant. As an example, during assembly the first endothermic reactant may be loaded through one of the initially open ends of the chamber 106 .
  • the cooling device 100 may also include an inner conduit 216 through which the target fluid flows from the target fluid inlet 102 to the target fluid outlet 104 in thermal communication with, but fluidly isolated from, the endothermic reactants present in the chamber 106 .
  • the inner conduit 216 may be configured to increase the surface area available for heat transfer.
  • the inner conduit 216 may include one or more inner helical conduits 216 .
  • the inner helical conduits 216 fluidly communicate with the target fluid inlet 102 and the target fluid outlet 104 , and provide flow paths for the target fluid to be cooled.
  • the chamber 106 surrounds the inner helical conduits 216 as illustrated in FIG. 3 .
  • the inner conduits 216 may have any other suitable configuration, shape or profile that increases their lengths, increases their outer surface areas, and/or maximizes their thermal contact with the endothermic reactants.
  • the inner helical conduits 216 may be constructed of a thermally conductive material providing adequate heat transfer such as, for example, various metals, e.g., stainless steel, titanium, aluminum, or brass, and certain thermally conductive plastics.
  • the inner helical conduits 216 may be constructed of medical grade conductive materials to ensure against contamination of the target fluid for medical uses. If needed, the inside and/or outside surfaces of the inner helical conduits 216 may be coated with biocompatible or protective barrier films, as appreciated by persons skilled in the art.
  • an end plate 110 may be attached to the chamber 106 at each end of the chamber 106 , and may be constructed to accommodate the ends of the inner helical conduits 216 and support the inner helical conduits 216 in the chamber 106 in a fixed manner.
  • each end plate 110 may include three through-bores respectively communicating with the three inner helical conduits 216 to facilitate flow-splitting from the target fluid inlet 102 and flow-merging to the target fluid outlet 104 .
  • An end cap 112 may also be secured by any suitable means (e.g., through the use of an adhesive) to the outside of the end plate 110 and/or the chamber 106 at each end of the chamber 106 when the cooling device 100 is assembled.
  • the chamber 106 may also be surrounded by an insulating material (not specifically shown) to ensure a minimum amount of heat transfer into the cooling device 100 from the outside environment.
  • FIG. 3 is a cut-away view of a portion of the fluid cooling device 100 .
  • FIG. 3 illustrates the three inner helical conduits 216 of the present example after installation in the surrounding chamber 106 .
  • the total amount of heat removed from the target fluid as it flows from the inlet side to the outlet side of the chamber 106 , and the rate of heat removal are increased by splitting the flow into more than one inner conduit 216 and by coiling the inner conduits 216 so as to increase their lengths from inlet to outlet.
  • the coiled or helical shapes are but one example; other examples include serpentine shapes and various other multi-turn configurations.
  • the inner conduits 216 may be provided with cooling fins.
  • FIG. 4 is a cross-sectional elevation view of another example of a fluid cooling device 400 according to the present teachings.
  • the cooling device 400 includes a target fluid inlet 102 and a target fluid outlet 104 , which in this example include female and male Luer-type fittings, respectively.
  • the cooling device 400 also includes inner helical conduits 216 fluidly communicating with the target fluid inlet 102 and the target fluid outlet 104 and providing flow paths for the target fluid to be cooled.
  • the cooling device 400 includes a chamber 106 surrounding the inner helical conduits 216 and containing a first endothermic reactant.
  • FIG. 4 also illustrates an insulation layer 436 surrounding the chamber 106 which may be included in the cooling device 400 , as described above.
  • the chamber 106 further includes a reactant inlet 414 selectively alterable from a closed state to an open state.
  • the reactant inlet 414 includes a frangible or openable barrier 420 spanning the internal cross-section of the chamber 106 .
  • the barrier 420 may divide the chamber 106 into a first region 432 containing the first endothermic reactant (e.g., ammonium nitrate) and a second region 428 containing the second endothermic reactant (e.g., water).
  • the first endothermic reactant is isolated from the second endothermic reactant by the barrier 420 and thus no endothermic reaction occurs.
  • an opening 440 is created to provide a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant for initiating the endothermic reaction and cooling the target fluid in the inner helical conduits 216 .
  • the first endothermic reactant may flow from the first region 432 into the second region 428 and thus into contact with the second endothermic reactant. More generally, at least one of the reactants is flowable so that interaction among the reactants occurs after the opening 440 in the barrier 420 has been formed.
  • the barrier 420 may be opened by any suitable user-actuated opening mechanism 424 .
  • the mechanism 424 may include a button or knob that, when actuated by the user (e.g., pressed, pulled, slid, rotated, etc.), actuates a puncturing device 438 that breaks the barrier 420 and hence alters the reactant inlet 414 to the open state by creating the opening 440 , which allows the first and second endothermic reactants to mix or combine within the chamber 106 .
  • terms such as “mix” and “combine” encompass any type of contact or interaction between reactants that results in the endothermic reaction utilized as the cooling mechanism according to the present teachings.
  • the mechanism 424 may include or operate as a switch that, when actuated by the user, moves the barrier 420 or a portion thereof (e.g., a valve, shutter, or sliding mechanism) to an open state, thereby creating the opening 440 and allowing the second endothermic reactant to flow.
  • the element 438 may represent any suitable mechanical linkage between the mechanism 424 and the barrier 420 .
  • the mechanism 424 may be linked to the barrier 420 such that pushing or pulling the mechanism 424 translates or rotates all or part of the barrier 420 to create the opening 440 .
  • the mechanism 424 may be configured such that sliding the mechanism 424 a short distance causes the barrier 420 to open in the manner of a shutter.
  • breaking as used in conjunction with altering the barrier 420 encompasses any means by which the opening 440 may be created (e.g., puncturing, moving the barrier 420 or a portion thereof, etc.), and thus in this context terms such as “breaking” and “opening” are used interchangeably.
  • the cooling device 400 may be shaken or agitated by the user to promote the mixing of the reactants.
  • FIG. 5 is a flow diagram illustrating an example of a method for cooling a target fluid according to the present teachings.
  • the method may be implemented by utilizing a cooling device 100 or 400 such as described above and illustrated in FIGS. 1-4 .
  • the first step 502 in the method generally includes flowing the target fluid through a target fluid inlet into an inner conduit or conduits of a cooling device.
  • the target fluid may include, for example, saline solution or any other fluid desired to be cooled in a particular application.
  • the cooling device of the present example may include a chamber surrounding the inner conduit and containing a first endothermic reactant (e.g., ammonium nitrate).
  • the chamber may include a reactant inlet that is selectively alterable from a closed state to an open state.
  • the reactant inlet may be internal or external to the chamber as described above.
  • the reactant inlet When the reactant inlet is in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs.
  • the second step 504 in the present example includes altering the reactant inlet from the closed state to the open state. Consequently, the reactant inlet provides a flow path for enabling the second endothermic reactant (e.g., water) to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and cooling the target fluid in the inner conduit.
  • the target fluid may be cooled to a temperature of, for example, 3 to 4 degrees Celsius, or a variety of other temperatures, depending on the particular application of the method.
  • the second step 504 may be performed prior to carrying out the first step 504 , so as to allow the reaction to begin before flowing the target fluid through the target fluid inlet.
  • the third step 506 in the present example includes flowing the target fluid through a target fluid outlet of the cooling device to a selected destination for the cooled target fluid such as into a receiving tube.
  • the cooled-fluid-receiving tube may include IV tubing for use in the medical field.
  • FIG. 6 is a flow diagram illustrating an example of a method for treating a patient according to the present teachings.
  • the present method may be used, for example, in the treatment of cardiac arrest patients in the pre-hospital or in-hospital settings.
  • the present method may also be used, as another example, in stroke recovery therapy.
  • the first step 602 in the method generally includes flowing a target fluid to be cooled from a reservoir.
  • the target fluid reservoir may include, for example, an IV bag containing a suitable intravenous fluid such as saline solution, and which may additionally include a therapeutically active drug if indicated for the specific situation.
  • a drug may be added to the saline solution after the saline solution has exited a cooling device.
  • the second step 604 in the method includes flowing the target fluid through a target fluid inlet and into an inner conduit(s) of the cooling device, as described above in conjunction with FIG. 5 .
  • the third step 606 in the method includes altering a reactant inlet from a closed state to an open state, as described above. As discussed above in conjunction with FIG. 5 , the reactant inlet may be altered from the closed state to the open state prior to flowing the target fluid through the target fluid inlet of the cooling device, so as to allow the reaction to commence prior to the target fluid entering the inner conduit(s) of the cooling device.
  • the fourth step 608 in the method includes flowing the target fluid through a target fluid outlet of the cooling device into a cooled-fluid-receiving tube, as described above.
  • the fifth step 610 includes administering to the patient the target fluid in the cooled-fluid-receiving tube intravenously until, for example, a state of hypothermia is reached in the patient.
  • Administering the cooled target fluid to the patient may include adding therapeutically active drugs to the cooled target fluid.
  • the fifth step 610 may include administering the cooled target fluid to the patient to begin induced hypothermia therapy in the pre-hospital setting, although a state of induced hypothermia in the patient may not be reached until the patient is, for example, in the in-hospital setting.
  • the fifth step 610 may include intravenously administering the cooled target fluid to the patient in order to significantly reduce the core body temperature of the patient, with or without the patient ever reaching a state of hypothermia.
  • FIG. 7 is a schematic of an intravenous target fluid delivery system 700 according to the present teachings.
  • the intravenous target fluid delivery system 700 includes an IV target fluid reservoir 702 , a cooling device 704 , and a cooled IV target fluid receiving tube 708 .
  • the IV target fluid reservoir 702 contains an IV target fluid to be cooled in the cooling device 704 .
  • the IV target fluid reservoir 702 may include a standard IV bag, for example.
  • the IV target fluid may include saline solution, and the saline solution may include therapeutically active drugs.
  • the IV target fluid reservoir 702 fluidly communicates with a target fluid inlet of the cooling device 704 .
  • the target fluid inlet may generally be configured to accommodate the size of any inlet tubing or fitting that fluidly couples the IV target fluid reservoir 702 to the target fluid inlet of the cooling device 704 .
  • the cooling device 704 may generally be configured as discussed above with respect to FIGS. 1 through 4 .
  • the cooling device 704 may include the target fluid inlet through which the IV target fluid to be cooled may enter the cooling device 704 , and a target fluid outlet through which the cooled IV target fluid may exit the cooling device 704 , the target fluid outlet being in fluid communication with the cooled IV target fluid receiving tube 708 .
  • the cooling device 704 includes a chamber surrounding one or more inner conduits between the target fluid inlet and the target fluid outlet, and contains a first endothermic reactant.
  • the inner conduit(s) fluidly communicates with the target fluid inlet and the target fluid outlet, and provides one or more flow paths for the IV target fluid to be cooled.
  • the chamber includes a reactant inlet that is selectively alterable from a closed state to an open state. In the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs. In the open state, the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and consequently cooling the IV target fluid in the inner conduit(s).
  • the second endothermic reactant may be flowed into the chamber via the reactant inlet by, for example, an external second endothermic reactant supply 706 (e.g., a syringe or other external source of the second endothermic reactant).
  • the second endothermic reactant may be provided internally within the cooling device 704 as described above in conjunction with FIG. 4 .
  • the first endothermic reactant may not be preloaded in the chamber and may be flowed into the chamber via the reactant inlet by, for example, an external first endothermic reactant supply.
  • the cooled IV target fluid receiving tube 708 is configured for intravenously administering the cooled IV target fluid to a patient.
  • the cooled IV target fluid receiving tube 708 may include, for example, an IV catheter or any other suitable IV fluid delivery device for administering the cooled IV target fluid to the patient.
  • Therapeutically active drugs may be added to the cooled IV target fluid prior to administering the cooled IV target fluid to the patient.
  • the cooled IV target fluid may be utilized to reduce the core body temperature of the patient. In one example, the cooled IV target fluid may be administered to the patient until the patient reaches a state of hypothermia.

Abstract

A cooling device includes a target fluid inlet, a target fluid outlet, an inner conduit, and a chamber surrounding the inner conduit. The inner conduit communicates with the target fluid inlet and the target fluid outlet, and provides a flow path for a target fluid to be cooled. The chamber contains a first endothermic reactant and includes a reactant inlet selectively alterable from a closed state to an open state. When the reactant inlet is in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs. When the reactant inlet is in the open state, the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and cooling the target fluid in the inner conduit.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation application of U.S. patent application Ser. No. 14/054,315, filed Oct. 15, 2013 and titled “RAPID FLUID COOLING DEVICES AND METHODS FOR COOLING FLUIDS,” which claims the benefit of U.S. patent application Ser. No. 12/711,749, filed Feb. 24, 2010, titled “RAPID FLUID COOLING DEVICES AND METHODS FOR COOLING FLUIDS,” and patented as U.S. Pat. No. 8,608,696, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/154,972, filed Feb. 24, 2009, titled “RAPID FLUID COOLING DEVICES AND METHODS FOR COOLING FLUIDS;” the contents of which are incorporated by reference herein in their entireties.
  • TECHNICAL FIELD
  • The present invention relates generally to fluid cooling devices. More particularly, the present invention relates to the cooling of fluids by endothermic reaction.
  • BACKGROUND
  • The cooling of core body temperature, such as for inducing hypothermia, is a medical treatment increasingly being used to treat patients as part of various medical-related procedures. Administering cooled intravenous fluids to induce hypothermia in cardiac arrest patients in the pre-hospital setting has been found to improve the likelihood of those patients being subsequently discharged from the hospital neurologically intact. Induced hypothermia therapy has proven effective in postponing damage to tissues caused by insufficient blood flow and oxygen deprivation. The smaller the time difference between cardiac arrest and induced hypothermia, the higher the likelihood of successful treatment. While there are in-hospital products available for inducing hypothermia, these products are not feasible for use in the pre-hospital setting.
  • The cooling of intravenous fluids for use in the pre-hospital setting is currently achieved though the use of conventional, bulky refrigeration units or simply ice-filled containers. Primary responders are typically unable to carry both conventional refrigerators and cardiac arrest patients simultaneously on-board a vehicle (e.g., ambulance, helicopter, etc.), or at least it is impractical to do so, for various reasons such as the space required for the refrigeration unit or ice-filled container and the fact that induced hypothermia as a treatment will be indicated in only a small fraction of the emergency situations encountered. Consequently, a second emergency vehicle carrying a refrigeration unit is required to intercept the primary responder and supply the primary responder with cooled intravenous fluids to administer to the patient. Once the cooled fluids are taken out of the refrigerator or ice-filled container, the fluids immediately begin to warm and there is currently no method available to effectively stop the warming process.
  • In recent years, there has been evidence supporting the use of induced hypothermia therapy in various other medical applications, including cardiac surgery and stroke recovery. As more medical discoveries are made, the potential uses of cooled fluids are likely to increase in both the pre-hospital and in-hospital settings.
  • In view of the foregoing, there is an ongoing need for cost-effective, efficient, portable, and compact fluid cooling devices for use in the medical field in general, and for use in rapidly cooling intravenous fluids in particular such as for inducing hypothermia in patients requiring medical attention, as well as for use in various non-medical fields.
  • SUMMARY
  • To address the foregoing problems, in whole or in part, and/or other problems that may have been observed by persons skilled in the art, the present disclosure provides methods, processes, systems, apparatus, instruments, and/or devices, as described by way of example in implementations set forth below.
  • According to one implementation, a cooling device includes a target fluid inlet, a target fluid outlet, an inner conduit, and a chamber surrounding the inner conduit. The inner conduit fluidly communicates with the target fluid inlet and the target fluid outlet, and provides a flow path for a target fluid to be cooled. The chamber surrounding the inner conduit contains a first endothermic reactant and includes a reactant inlet selectively alterable from a closed state to an open state. When the reactant inlet is in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs. When the reactant inlet is in the open state, the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and cooling the target fluid in the inner conduit.
  • According to another implementation, the reactant inlet of the cooling device may further include a barrier. When the reactant inlet is in the closed state, the barrier may divide the chamber into a first region containing the first endothermic reactant, and a second region containing the second endothermic reactant. The cooling device may include an actuator configured to open the barrier wherein the reactant inlet is altered to the open state.
  • According to another implementation, the cooling device includes a pressure release valve adapted to communicate with the chamber, wherein the pressure release valve allows flow from the chamber to a receptacle adapted to communicate with the pressure release valve when the pressure in the chamber increases to a predetermined critical pressure.
  • According to another implementation, at least a portion of the chamber is flexible such that the volume of the chamber is expandable.
  • According to another implementation, the cooling device includes an insulating material surrounding the chamber.
  • According to another implementation, the target fluid includes saline solution. In another implementation, the target fluid further includes a therapeutically active drug.
  • According to another implementation, the reactant inlet comprises a fitting configured for connection to an external source of the second endothermic reactant. In another implementation, the reactant inlet comprises a valve.
  • According to another implementation, an intravenous target fluid delivery system includes an IV target fluid reservoir, a cooling device, and a cooled IV target fluid receiving tube. The IV target fluid reservoir contains an IV target fluid to be cooled in the cooling device. The IV target fluid reservoir fluidly communicates with a target fluid inlet of the cooling device. The cooled IV target fluid receiving tube fluidly communicates with a target fluid outlet of the cooling device, and is configured for intravenously administering the cooled IV target fluid to a patient.
  • According to another implementation, the first endothermic reactant includes an inorganic salt such as, for example, ammonium nitrate, ammonium chloride, potassium chloride, etc. The second endothermic reactant may, for example, include water.
  • According to another implementation, the reactant inlet includes a barrier and in the closed state, the barrier divides the chamber into a first region containing the first endothermic reactant, and a second region containing the second endothermic reactant. In some implementations, an actuator is configured to open the barrier wherein the reactant inlet is altered to an open state. The actuator may be configured to puncture the barrier. Alternatively, the actuator may be configured to move at least a portion of the barrier to create an opening therethrough.
  • In some implementations, the IV target fluid reservoir may include an IV bag. The cooled IV target fluid receiving tube may include an IV catheter.
  • According to another implementation, a method is provided for cooling a target fluid. In the method, a target fluid is flowed from a target fluid inlet of a cooling device, through the cooling device, and to a target fluid outlet of the cooling device. While flowing the target fluid, heat is removed from the target fluid by conducting an endothermic reaction in the cooling device.
  • According to another implementation, a method is provided for treating a patient. A target fluid to be cooled is flowed from a reservoir through a target fluid inlet of a cooling device, and into an inner conduit of the cooling device. The cooling device includes a chamber surrounding the inner conduit and containing a first endothermic reactant. The chamber includes a reactant inlet selectively alterable from a closed state to an open state, wherein in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs. The endothermic reaction is initiated and the target fluid in the inner conduit is cooled by altering the reactant inlet from the closed state to the open state, wherein the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber. The cooled target fluid is flowed through a target fluid outlet of the cooling device into a cooled-fluid-receiving tube. The cooled target fluid is administered to the patient intravenously to reduce the patient's core body temperature.
  • In some implementations, the target fluid includes saline solution. In further implementations, the target fluid further comprises a therapeutically active drug.
  • Other devices, apparatus, systems, methods, features and advantages of the invention will be or will become apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features and advantages be included within this description, be within the scope of the invention, and be protected by the accompanying claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention can be better understood by referring to the following figures. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention. In the figures, like reference numerals designate corresponding parts throughout the different views.
  • FIG. 1 is a simplified perspective view of an example of a fluid cooling device according to the present teachings.
  • FIG. 2 is an exploded perspective view of an example of a fluid cooling device according to the present teachings.
  • FIG. 3 is a cut-away view of a portion of a chamber surrounding inner helical conduits according to the present teachings.
  • FIG. 4 is a cross-sectional elevation view of another example of a fluid cooling device according to the present teachings that illustrates a barrier within the chamber.
  • FIG. 5 is a flow diagram illustrating a method for cooling a target fluid according to the present teachings.
  • FIG. 6 is a flow diagram illustrating a method for treating a patient according to the present teachings.
  • FIG. 7 is a schematic of an intravenous target fluid delivery system according to the present teachings.
  • DETAILED DESCRIPTION
  • By way of example, FIGS. 1-7 illustrate various implementations of a fluid cooling device, a method for cooling a target fluid, a method for treating a patient, and a related system. The various implementations provide a highly effective, compact, transportable, and efficient solution for rapidly cooling a target fluid for use, as for example, in the pre-hospital setting for intravenously inducing hypothermia or otherwise significantly reducing the core body temperature in cardiac arrest patients as well as for other medical uses and non-medical uses. As noted above, the less the difference in time between cardiac arrest and induced hypothermia, the higher the likelihood of success in subsequently discharging cardiac arrest patients from the hospital neurologically intact. Hypothermia is defined as a body temperature significantly below 37° C., and there are various levels of hypothermia. For example, mild hypothermia is defined as a body temperature of about 34° C., moderate hypothermia is defined as a body temperature of about 23-32° C. and profound hypothermia is defined as a body temperature of about 12-20° C. See Stedman's Medical Dictionary, 26th Edition, 1995. A fluid cooling device consistent with the present teachings has experimentally demonstrated superior performance in providing a cooled target fluid for use in the pre-hospital setting, as compared with the current method of cooling fluids in the pre-hospital setting via conventional refrigeration. For example, a fluid cooling device according to the present teachings has experimentally cooled a target fluid (i.e., saline solution) from room temperature to about 4° C. in about 1.5 to 2.0 minutes, wherein ammonium nitrate and water were utilized as the endothermic reactants in the cooling device. The cooling device according to the present teachings may be sized and configured for compatibility with associated fluid delivery components. For example, the cooling device may be easily connected to standardized intravenous delivery equipment to function as an in-line, on-demand chilling device. All or part of the cooling device may be sterilizable and reusable, or alternatively may be configured as a disposable single-use device.
  • FIG. 1 is a simplified perspective view of an example of a fluid cooling device 100 according to the present teachings. The cooling device 100 generally includes a target fluid inlet 102 through which a target fluid (e.g., saline solution) to be cooled may enter the cooling device 100, and a target fluid outlet 104 through which the target fluid may exit the cooling device 100. The cooling device 100 also generally includes a chamber 106 surrounding one or more inner conduits (not shown in FIG. 1) between the target fluid inlet 102 and the target fluid outlet 104, and containing a first endothermic reactant (e.g., ammonium nitrate, ammonium chloride, potassium chloride, or the like). The first endothermic reactant may, for example, be packed into the chamber 106 in any suitable form such as powder, pellets, grains, gel, colloid, suspension, liquid, or the like, and may fill the volume in the chamber 106 around the inner conduit or conduits. The inner conduit fluidly communicates with the target fluid inlet 102 and the target fluid outlet 104, and provides one or more flow paths for a target fluid to be cooled. An example of an inner conduit provided as one or more inner helical conduits is described below with respect to FIGS. 2 and 3. Those skilled in the art will appreciate that the inner conduit(s) may be constructed of various materials (e.g., medical grade metals, thermally conductive plastics, and the like) and may include various shapes and cross-sectional areas so as to optimize the available surface area for heat transfer. The target fluid inlet 102 may generally be configured to accommodate the size of any inlet tubing or fitting connected to the target fluid inlet 102. The target fluid outlet 104 may generally be configured to accommodate the size of any outlet tubing or fitting connected to the target fluid outlet 104. The chamber 106 also generally includes a reactant inlet 108 that is selectively alterable from a closed state to an open state. The reactant inlet 108 may include, for example, a Luer-Lock™ port or any valve or fitting switchable between closed and open states, or an openable or frangible barrier. In the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs. In the open state, the reactant inlet 108 provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber 106 for initiating the endothermic reaction and consequently cooling the target fluid in the inner conduit. As in the case of the first endothermic reactant, the second endothermic reactant may be provided in any suitable form (e.g., solid, semi-solid, colloidal, liquid, etc.). Moreover, the first and/or second endothermic reactant may include any suitable additive that promotes or optimizes the endothermic reaction.
  • As appreciated by persons skilled in the art, various types of endothermic reactions exist and thus the specific reactants utilized in the cooling device 100 will depend on the particular endothermic reaction being implemented. As examples, ammonium nitrate, ammonium chloride, or potassium chloride may be utilized as the first endothermic reactant, and in each case, water may be utilized as the flowable second endothermic reactant. Other flowable materials may also be suitable for serving as the second endothermic reactant. Generally, the cooling device 100 may employ any combination of reactants that, when combined, result in an endothermic reaction suitable for rapid cooling of a selected target fluid such as, for example, saline solution. The second endothermic reactant may be flowed into the chamber 106 via the reactant inlet 108 by any suitable means such as, for example, utilizing a syringe (not shown) or other external source of reactant. Alternatively, the second endothermic reactant may be provided internally within the cooling device as described by example below in conjunction with FIG. 4. Those skilled in the art will appreciate that in some implementations, the first endothermic reactant may not be pre-loaded in the chamber 106. For example, both the first and second endothermic reactants may be supplied from external sources (e.g., syringes) into the chamber 106 via the reactant inlet 108 in any order (or from two separate reactant inlets) for initiating the endothermic reaction. Having the first endothermic reactant and/or the second endothermic reactant preloaded in the chamber 106 may be particularly useful in implementations in which the cooling device 100 is utilized to rapidly cool intravenous fluids in the pre-hospital setting, for example.
  • In the present example, the chamber 106 may be constructed of, for example, PVC plastic. At each end of the chamber 106, an end plate 110 may be attached to the chamber 106 by any suitable means, and may be constructed to accommodate the ends of the inner conduits. An end cap 112 may also be secured by any suitable means to the end plate 110 and/or chamber 106 at each end of the chamber 106. The end caps 112 may be tapered or otherwise configured to accommodate the positions of the inner conduit(s) and/or the flow transitions between the inner conduit(s) of the chamber 106 and the target fluid inlet 102 and target fluid outlet 104. Both the end plates 110 and the end caps 112 may be constructed of, for example, ABS plastic. In some implementations, a pressure release valve 114 may optionally be provided to communicate with the chamber 106 such that pressure may release from the chamber 106 to, for example, a receptacle (not shown) adapted to communicate with the pressure release valve 114 when the pressure in the chamber 106 increases to a predetermined critical pressure. For example, if a syringe is used to admit the second endothermic reactant into the chamber 106 via the reactant inlet 108, the pressure release valve 114 may be used to release any excess pressure in the chamber 106 resulting from utilization of the syringe. The use of a receptacle at the pressure release valve 114 maintains the cooling device 100 as a closed system and ensures that the endothermic reactants remain isolated from the environment. Alternatively, element 114 may represent a fluid connection to a flexible chamber that allows for expansion. As a further alternative, at least a portion of the chamber 106 may be flexible to allow for expansion. The chamber 106 may also be surrounded by an insulating material (e.g., polypropylene foam covered in vinyl fabric) to ensure a minimum amount of heat transfer into the cooling device 100 from the outside environment.
  • The cooling device 100 in FIG. 1 may be used to rapidly, effectively and reliably supply cooled fluids in a manner which does not require the aid of any other device. In one specific yet non-limiting example, the cooling device 100 may be utilized to quickly supply cooled saline solution for intravenous administration to cardiac arrest patients in the pre-hospital setting, so as to reduce the core body temperature of the patients. The cooling device 100 is completely isolated from the external environment, ensuring no contamination of the target liquid, any potential user, and any potential patient while the cooling device 100 is in use. The cooling device 100 may also be utilized in various other settings, e.g., stroke therapy and cardiac surgery. More generally, the cooling device 100 may be utilized in a wide variety of non-medical as well as medical applications for cooling various liquids, gases, vapors, suspensions, etc. The cooling device 100 may be portable, easily storable and easily disposed of after use. The cooling device 100 may be easily connected to input tubing and output tubing for use as an in-line device, as described in further detail below with respect to FIG. 7. The cooling device 100 according to the present teachings may be manufactured in varying sizes and dimensions so as to allow for various temperatures of the target fluid at the target fluid outlet 104 of the cooling device 100. For example, reducing the length of the cooling device 100 may result in a higher temperature of the target fluid at the target fluid outlet 104 as a result of a decrease in surface area utilized for heat transfer. As another example, the cooling device 100 according to the present teachings may be manufactured with varying amounts of the first endothermic reactant so as to allow for various temperatures of the target fluid at the target fluid outlet 104 of the cooling device 100. As yet another example, different cooling devices 100 according to the present teachings may be manufactured with different endothermic reactants so as to allow for various temperatures of the target fluid at the target fluid outlet 104 of the cooling devices 100. In some implementations a target fluid flowing through the cooling device 100 may be cooled from room temperature down to about 3 or 4° C. upon exit from the cooling device 100. The time required for this amount of cooling to occur from the target fluid inlet 102 to the target fluid outlet 104 will depend on a variety of factors, including for example the volume of the chamber 106 and of the reactant loaded therein, the internal diameter and length of the inner conduit(s) and thus the resulting flow rate and residence time of the target fluid in the chamber 106, as well as the specific endothermic reactants utilized.
  • FIG. 2 is an exploded perspective view of an example of the fluid cooling device 100 discussed above. The fluid cooling device 100 may be utilized as described above with respect to FIG. 1, or as otherwise described in the present teachings. The cooling device 100 also includes the chamber 106 containing the first endothermic reactant. As an example, during assembly the first endothermic reactant may be loaded through one of the initially open ends of the chamber 106. The cooling device 100 may also include an inner conduit 216 through which the target fluid flows from the target fluid inlet 102 to the target fluid outlet 104 in thermal communication with, but fluidly isolated from, the endothermic reactants present in the chamber 106. The inner conduit 216 may be configured to increase the surface area available for heat transfer. Thus, in the present example, the inner conduit 216 may include one or more inner helical conduits 216. When the cooling device 100 is assembled, the inner helical conduits 216 fluidly communicate with the target fluid inlet 102 and the target fluid outlet 104, and provide flow paths for the target fluid to be cooled. When the cooling device 100 is assembled, the chamber 106 surrounds the inner helical conduits 216 as illustrated in FIG. 3. As an alternative to the illustrated helical configuration, the inner conduits 216 may have any other suitable configuration, shape or profile that increases their lengths, increases their outer surface areas, and/or maximizes their thermal contact with the endothermic reactants.
  • In the present example, the inner helical conduits 216 may be constructed of a thermally conductive material providing adequate heat transfer such as, for example, various metals, e.g., stainless steel, titanium, aluminum, or brass, and certain thermally conductive plastics. In some implementations, the inner helical conduits 216 may be constructed of medical grade conductive materials to ensure against contamination of the target fluid for medical uses. If needed, the inside and/or outside surfaces of the inner helical conduits 216 may be coated with biocompatible or protective barrier films, as appreciated by persons skilled in the art. When the cooling device 100 is assembled, an end plate 110 may be attached to the chamber 106 at each end of the chamber 106, and may be constructed to accommodate the ends of the inner helical conduits 216 and support the inner helical conduits 216 in the chamber 106 in a fixed manner. For instance, in the present example in which three inner helical conduits 216 are utilized, each end plate 110 may include three through-bores respectively communicating with the three inner helical conduits 216 to facilitate flow-splitting from the target fluid inlet 102 and flow-merging to the target fluid outlet 104. An end cap 112 may also be secured by any suitable means (e.g., through the use of an adhesive) to the outside of the end plate 110 and/or the chamber 106 at each end of the chamber 106 when the cooling device 100 is assembled. As also noted above, the chamber 106 may also be surrounded by an insulating material (not specifically shown) to ensure a minimum amount of heat transfer into the cooling device 100 from the outside environment.
  • FIG. 3 is a cut-away view of a portion of the fluid cooling device 100. Specifically, FIG. 3 illustrates the three inner helical conduits 216 of the present example after installation in the surrounding chamber 106. In this example, the total amount of heat removed from the target fluid as it flows from the inlet side to the outlet side of the chamber 106, and the rate of heat removal, are increased by splitting the flow into more than one inner conduit 216 and by coiling the inner conduits 216 so as to increase their lengths from inlet to outlet. The coiled or helical shapes are but one example; other examples include serpentine shapes and various other multi-turn configurations. As another example, the inner conduits 216 may be provided with cooling fins. Generally, no limitation is placed on the internal diameter(s) of the inner conduit(s) 216, so long as target fluid flow therethrough is unimpeded and travel time is sufficient to ensure a desired amount of heat rejection to the surrounding chamber 106. It can also be seen in FIG. 3 that an ample volume is provided around and between the inner conduits 216 for filling the chamber 106 with the selected endothermic reactants. Upon initiation of the endothermic reaction in the chamber 106, thermal gradients are established from the inner conduits 216 and outward in a multitude of directions.
  • FIG. 4 is a cross-sectional elevation view of another example of a fluid cooling device 400 according to the present teachings. As in the previous example, the cooling device 400 includes a target fluid inlet 102 and a target fluid outlet 104, which in this example include female and male Luer-type fittings, respectively. The cooling device 400 also includes inner helical conduits 216 fluidly communicating with the target fluid inlet 102 and the target fluid outlet 104 and providing flow paths for the target fluid to be cooled. The cooling device 400 includes a chamber 106 surrounding the inner helical conduits 216 and containing a first endothermic reactant. FIG. 4 also illustrates an insulation layer 436 surrounding the chamber 106 which may be included in the cooling device 400, as described above. The chamber 106 further includes a reactant inlet 414 selectively alterable from a closed state to an open state. In this example, the reactant inlet 414 includes a frangible or openable barrier 420 spanning the internal cross-section of the chamber 106. In the closed state, the barrier 420 may divide the chamber 106 into a first region 432 containing the first endothermic reactant (e.g., ammonium nitrate) and a second region 428 containing the second endothermic reactant (e.g., water). In the closed state, the first endothermic reactant is isolated from the second endothermic reactant by the barrier 420 and thus no endothermic reaction occurs. When the reactant inlet 414 is altered to the open state, such as by breaking, puncturing or otherwise opening the barrier 420, an opening 440 is created to provide a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant for initiating the endothermic reaction and cooling the target fluid in the inner helical conduits 216. Alternatively, the first endothermic reactant may flow from the first region 432 into the second region 428 and thus into contact with the second endothermic reactant. More generally, at least one of the reactants is flowable so that interaction among the reactants occurs after the opening 440 in the barrier 420 has been formed.
  • In the present example, the barrier 420 may be opened by any suitable user-actuated opening mechanism 424. For example, the mechanism 424 may include a button or knob that, when actuated by the user (e.g., pressed, pulled, slid, rotated, etc.), actuates a puncturing device 438 that breaks the barrier 420 and hence alters the reactant inlet 414 to the open state by creating the opening 440, which allows the first and second endothermic reactants to mix or combine within the chamber 106. As used herein, terms such as “mix” and “combine” encompass any type of contact or interaction between reactants that results in the endothermic reaction utilized as the cooling mechanism according to the present teachings. The exact mechanics of the interaction between the endothermic reactants and the particular reaction kinetics will depend on the type of endothermic reaction conducted in a given implementation, one non-limiting example being the dissolution of certain nitrates or chlorides in a suitable solvent such as water as noted above. As another example, the mechanism 424 may include or operate as a switch that, when actuated by the user, moves the barrier 420 or a portion thereof (e.g., a valve, shutter, or sliding mechanism) to an open state, thereby creating the opening 440 and allowing the second endothermic reactant to flow. In this latter case, the element 438 may represent any suitable mechanical linkage between the mechanism 424 and the barrier 420. For instance, the mechanism 424 may be linked to the barrier 420 such that pushing or pulling the mechanism 424 translates or rotates all or part of the barrier 420 to create the opening 440. As another alternative, the mechanism 424 may be configured such that sliding the mechanism 424 a short distance causes the barrier 420 to open in the manner of a shutter. In all of the foregoing alternatives, the term “breaking” as used in conjunction with altering the barrier 420 encompasses any means by which the opening 440 may be created (e.g., puncturing, moving the barrier 420 or a portion thereof, etc.), and thus in this context terms such as “breaking” and “opening” are used interchangeably. Moreover, in conjunction with breaking or opening the barrier 420, the cooling device 400 may be shaken or agitated by the user to promote the mixing of the reactants.
  • FIG. 5 is a flow diagram illustrating an example of a method for cooling a target fluid according to the present teachings. The method may be implemented by utilizing a cooling device 100 or 400 such as described above and illustrated in FIGS. 1-4. The first step 502 in the method generally includes flowing the target fluid through a target fluid inlet into an inner conduit or conduits of a cooling device. The target fluid may include, for example, saline solution or any other fluid desired to be cooled in a particular application. The cooling device of the present example may include a chamber surrounding the inner conduit and containing a first endothermic reactant (e.g., ammonium nitrate). The chamber may include a reactant inlet that is selectively alterable from a closed state to an open state. The reactant inlet may be internal or external to the chamber as described above. When the reactant inlet is in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs. The second step 504 in the present example includes altering the reactant inlet from the closed state to the open state. Consequently, the reactant inlet provides a flow path for enabling the second endothermic reactant (e.g., water) to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and cooling the target fluid in the inner conduit. The target fluid may be cooled to a temperature of, for example, 3 to 4 degrees Celsius, or a variety of other temperatures, depending on the particular application of the method. In some implementations, the second step 504 may be performed prior to carrying out the first step 504, so as to allow the reaction to begin before flowing the target fluid through the target fluid inlet. The third step 506 in the present example includes flowing the target fluid through a target fluid outlet of the cooling device to a selected destination for the cooled target fluid such as into a receiving tube. In one example of one implementation of the present teachings, the cooled-fluid-receiving tube may include IV tubing for use in the medical field.
  • FIG. 6 is a flow diagram illustrating an example of a method for treating a patient according to the present teachings. The present method may be used, for example, in the treatment of cardiac arrest patients in the pre-hospital or in-hospital settings. The present method may also be used, as another example, in stroke recovery therapy. The first step 602 in the method generally includes flowing a target fluid to be cooled from a reservoir. The target fluid reservoir may include, for example, an IV bag containing a suitable intravenous fluid such as saline solution, and which may additionally include a therapeutically active drug if indicated for the specific situation. Alternatively, a drug may be added to the saline solution after the saline solution has exited a cooling device. The second step 604 in the method includes flowing the target fluid through a target fluid inlet and into an inner conduit(s) of the cooling device, as described above in conjunction with FIG. 5. The third step 606 in the method includes altering a reactant inlet from a closed state to an open state, as described above. As discussed above in conjunction with FIG. 5, the reactant inlet may be altered from the closed state to the open state prior to flowing the target fluid through the target fluid inlet of the cooling device, so as to allow the reaction to commence prior to the target fluid entering the inner conduit(s) of the cooling device. The fourth step 608 in the method includes flowing the target fluid through a target fluid outlet of the cooling device into a cooled-fluid-receiving tube, as described above. The fifth step 610 includes administering to the patient the target fluid in the cooled-fluid-receiving tube intravenously until, for example, a state of hypothermia is reached in the patient. Administering the cooled target fluid to the patient may include adding therapeutically active drugs to the cooled target fluid. As another example of an implementation of the present teachings, the fifth step 610 may include administering the cooled target fluid to the patient to begin induced hypothermia therapy in the pre-hospital setting, although a state of induced hypothermia in the patient may not be reached until the patient is, for example, in the in-hospital setting. As yet another example, the fifth step 610 may include intravenously administering the cooled target fluid to the patient in order to significantly reduce the core body temperature of the patient, with or without the patient ever reaching a state of hypothermia.
  • FIG. 7 is a schematic of an intravenous target fluid delivery system 700 according to the present teachings. The intravenous target fluid delivery system 700 includes an IV target fluid reservoir 702, a cooling device 704, and a cooled IV target fluid receiving tube 708. The IV target fluid reservoir 702 contains an IV target fluid to be cooled in the cooling device 704. The IV target fluid reservoir 702 may include a standard IV bag, for example. The IV target fluid may include saline solution, and the saline solution may include therapeutically active drugs. The IV target fluid reservoir 702 fluidly communicates with a target fluid inlet of the cooling device 704. The target fluid inlet may generally be configured to accommodate the size of any inlet tubing or fitting that fluidly couples the IV target fluid reservoir 702 to the target fluid inlet of the cooling device 704. The cooling device 704 may generally be configured as discussed above with respect to FIGS. 1 through 4. For example, the cooling device 704 may include the target fluid inlet through which the IV target fluid to be cooled may enter the cooling device 704, and a target fluid outlet through which the cooled IV target fluid may exit the cooling device 704, the target fluid outlet being in fluid communication with the cooled IV target fluid receiving tube 708. The cooling device 704 includes a chamber surrounding one or more inner conduits between the target fluid inlet and the target fluid outlet, and contains a first endothermic reactant. The inner conduit(s) fluidly communicates with the target fluid inlet and the target fluid outlet, and provides one or more flow paths for the IV target fluid to be cooled. The chamber includes a reactant inlet that is selectively alterable from a closed state to an open state. In the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs. In the open state, the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and consequently cooling the IV target fluid in the inner conduit(s). In the present example, the second endothermic reactant may be flowed into the chamber via the reactant inlet by, for example, an external second endothermic reactant supply 706 (e.g., a syringe or other external source of the second endothermic reactant). Alternatively, the second endothermic reactant may be provided internally within the cooling device 704 as described above in conjunction with FIG. 4. In some implementations, the first endothermic reactant may not be preloaded in the chamber and may be flowed into the chamber via the reactant inlet by, for example, an external first endothermic reactant supply. The cooled IV target fluid receiving tube 708 is configured for intravenously administering the cooled IV target fluid to a patient. The cooled IV target fluid receiving tube 708 may include, for example, an IV catheter or any other suitable IV fluid delivery device for administering the cooled IV target fluid to the patient. Therapeutically active drugs may be added to the cooled IV target fluid prior to administering the cooled IV target fluid to the patient. The cooled IV target fluid may be utilized to reduce the core body temperature of the patient. In one example, the cooled IV target fluid may be administered to the patient until the patient reaches a state of hypothermia.
  • In general, terms such as “communicate” and “in . . . communication with” (for example, a first component “communicates with” or “is in communication with” a second component) are used herein to indicate a structural, functional, mechanical, electrical, signal, optical, magnetic, electromagnetic, ionic or fluidic relationship between two or more components or elements. As such, the fact that one component is said to communicate with a second component is not intended to exclude the possibility that additional components may be present between, and/or operatively associated or engaged with, the first and second components.
  • It will be understood that various aspects or details of the invention may be changed without departing from the scope of the invention. Furthermore, the foregoing description is for the purpose of illustration only, and not for the purpose of limitation—the invention being defined by the claims.

Claims (18)

What is claimed is:
1. A cooling device comprising:
a target fluid inlet;
a target fluid outlet;
an inner conduit fluidly communicating with the target fluid inlet and the target fluid outlet, the inner conduit providing a flow path for a target fluid to be cooled; and
a chamber surrounding the inner conduit and containing a first endothermic reactant, the chamber including a reactant inlet selectively alterable from a closed state to an open state, wherein:
in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs; and
in the open state, the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and cooling the target fluid in the inner conduit.
2. The cooling device of claim 1, wherein the reactant inlet comprises a fitting configured for connection to an external source of the second endothermic reactant.
3. The cooling device of claim 1, wherein the first endothermic reactant comprises an inorganic salt.
4. The cooling device of claim 3, wherein the second endothermic reactant comprises water.
5. The cooling device of claim 1, wherein the inner conduit is one of a plurality of inner conduits fluidly communicating with the target fluid inlet and the target fluid outlet and providing a plurality of respective flow paths for the target fluid.
6. The cooling device of claim 5, wherein at least a portion of each inner conduit is helical.
7. The cooling device of claim 1, wherein the reactant inlet comprises a barrier and in the closed state, the barrier divides the chamber into a first region containing the first endothermic reactant, and a second region containing the second endothermic reactant.
8. The cooling device of claim 7, further comprising an actuator configured to open the barrier wherein the reactant inlet is altered to the open state.
9. The cooling device of claim 8, wherein the actuator is configured to puncture the barrier.
10. The cooling device of claim 8, wherein the actuator is configured to move at least a portion of the barrier to create an opening therethrough.
11. An intravenous target fluid delivery system comprising:
an IV target fluid reservoir including an IV target fluid to be cooled;
a cooling device including:
a target fluid inlet fluidly communicating with the IV target fluid reservoir;
a target fluid outlet;
an inner conduit fluidly communicating with the target fluid inlet and the target fluid outlet, the inner conduit providing a flow path for the IV target fluid to be cooled; and
a chamber surrounding the inner conduit and containing a first endothermic reactant, the chamber including a reactant inlet selectively alterable from a closed state to an open state, wherein in the closed state, the first endothermic reactant is isolated from a second endothermic reactant and no endothermic reaction occurs, and in the open state, the reactant inlet provides a flow path for enabling the second endothermic reactant to come into contact with the first endothermic reactant in the chamber for initiating the endothermic reaction and cooling the IV target fluid in the inner conduit; and
a cooled IV target fluid receiving tube fluidly communicating with the target fluid outlet, wherein the cooled IV target fluid receiving tube is configured for intravenously administering the cooled IV target fluid to a patient.
12. The intravenous target fluid delivery system of claim 11, wherein the IV target fluid comprises saline solution.
13. The intravenous target fluid delivery system of claim 12, wherein the IV target fluid further comprises a therapeutically active drug.
14. The intravenous target fluid delivery system of claim 11, wherein the reactant inlet comprises a fitting configured for connection to an external source of the second endothermic reactant.
15. The intravenous target fluid delivery system of claim 11, wherein the inner conduit is one of a plurality of inner conduits fluidly communicating with the target fluid inlet and the target fluid outlet and providing a plurality of respective flow paths for the target fluid.
16. The intravenous target fluid delivery system of claim 11, wherein the reactant inlet comprises a barrier and in the closed state, the barrier divides the chamber into a first region containing the first endothermic reactant, and a second region containing the second endothermic reactant.
17. The intravenous target fluid delivery system of claim 16, further comprising an actuator configured to open the barrier wherein the reactant inlet is altered to an open state.
18. The intravenous target fluid delivery system of claim 11, wherein the cooled IV target fluid receiving tube includes an IV catheter.
US14/452,642 2009-02-24 2014-08-06 Rapid fluid cooling devices and methods for cooling fluids Abandoned US20140364806A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/452,642 US20140364806A1 (en) 2009-02-24 2014-08-06 Rapid fluid cooling devices and methods for cooling fluids

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15497209P 2009-02-24 2009-02-24
US12/711,749 US8608696B1 (en) 2009-02-24 2010-02-24 Rapid fluid cooling devices and methods for cooling fluids
US14/054,315 US8808241B2 (en) 2009-02-24 2013-10-15 Rapid fluid cooling devices and methods for cooling fluids
US14/452,642 US20140364806A1 (en) 2009-02-24 2014-08-06 Rapid fluid cooling devices and methods for cooling fluids

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US14/054,315 Continuation US8808241B2 (en) 2009-02-24 2013-10-15 Rapid fluid cooling devices and methods for cooling fluids

Publications (1)

Publication Number Publication Date
US20140364806A1 true US20140364806A1 (en) 2014-12-11

Family

ID=49725676

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/711,749 Expired - Fee Related US8608696B1 (en) 2009-02-24 2010-02-24 Rapid fluid cooling devices and methods for cooling fluids
US14/054,315 Expired - Fee Related US8808241B2 (en) 2009-02-24 2013-10-15 Rapid fluid cooling devices and methods for cooling fluids
US14/452,642 Abandoned US20140364806A1 (en) 2009-02-24 2014-08-06 Rapid fluid cooling devices and methods for cooling fluids

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US12/711,749 Expired - Fee Related US8608696B1 (en) 2009-02-24 2010-02-24 Rapid fluid cooling devices and methods for cooling fluids
US14/054,315 Expired - Fee Related US8808241B2 (en) 2009-02-24 2013-10-15 Rapid fluid cooling devices and methods for cooling fluids

Country Status (1)

Country Link
US (3) US8608696B1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8608696B1 (en) * 2009-02-24 2013-12-17 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
KR102023650B1 (en) 2011-07-25 2019-09-20 네우로세이브, 인코포레이티드 Non-invasive systems, devices, and methods for selective brain cooling
CN104162213A (en) * 2014-08-27 2014-11-26 苏州万木春生物技术有限公司 Quick fluid cooling device
WO2016054165A1 (en) * 2014-10-01 2016-04-07 Novocor Medical Systems, Inc. Fluid cooling devices, systems and methods for cooling fluids
EP3534852B1 (en) 2016-11-02 2022-02-02 Miraki Innovation Think Tank LLC Devices for slurry generation
US11324673B2 (en) 2016-11-18 2022-05-10 Miraki Innovation Think Tank Llc Cosmetic appearance of skin
MX2019011995A (en) 2017-04-05 2020-01-20 Miraki Innovation Think Tank Llc Point of delivery cold slurry generation.
KR102589816B1 (en) 2017-04-05 2023-10-16 미라키 이노베이션 씽크 탱크 엘엘씨 Low-temperature slurry containment
US10500342B2 (en) 2017-08-21 2019-12-10 Miraki Innovation Think Tank Llc Cold slurry syringe
EP3527919A1 (en) * 2018-02-16 2019-08-21 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Endothermic salt regeneration for cooling and air-conditioning
US10636229B2 (en) * 2018-04-17 2020-04-28 Lyft, Inc. Black box with volatile memory caching

Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065235A (en) * 1976-06-01 1977-12-27 Tuthill Pump Company Gear pump
US4653577A (en) * 1986-01-23 1987-03-31 Shiley, Inc. Unitary heat exchanger and debubbler for a liquid
US5149321A (en) * 1990-10-10 1992-09-22 Klatz Ronald M Brain resuscitation device and method for performing the same
US5219274A (en) * 1992-08-10 1993-06-15 Tuthill Corporation Pump with internal pressure relief
US5395314A (en) * 1990-10-10 1995-03-07 Life Resuscitation Technologies, Inc. Brain resuscitation and organ preservation device and method for performing the same
US5429762A (en) * 1993-01-28 1995-07-04 Japan Pionics Co., Ltd. Cooling agent
US5494416A (en) * 1993-11-12 1996-02-27 Tuthill Corporation Magnetically driven positive displacement pump and thrust bearing assembly
US5584804A (en) * 1990-10-10 1996-12-17 Life Resuscitation Technologies, Inc. Brain resuscitation and organ preservation device and method for performing the same
US5827222A (en) * 1990-10-10 1998-10-27 Life Resuscitation Technologies, Inc. Method of treating at least one of brain and associated nervous tissue injury
US5840068A (en) * 1996-02-28 1998-11-24 Cartledge; Richard G. Rapid infusion system
US5913885A (en) * 1991-05-22 1999-06-22 Life Science Holdings, Inc. Brain cooling device and method for cooling
US5927273A (en) * 1996-03-08 1999-07-27 Life Resuscitation Technologies, Inc. Combined liquid ventilation and cardiopulmonary resuscitation method
US6158994A (en) * 1999-04-21 2000-12-12 Tuthill Corporation Grooved rotor for an internal gear pump
US6231595B1 (en) * 1998-03-31 2001-05-15 Innercool Therapies, Inc. Circulating fluid hypothermia method and apparatus
US6270324B1 (en) * 1999-10-26 2001-08-07 Tuthill Corp. Positive displacement pump and thrust bearing assembly
US20020045852A1 (en) * 1992-08-13 2002-04-18 Saab Mark A. Method for changing the temperature of a selected body region
US6554791B1 (en) * 1999-09-29 2003-04-29 Smisson-Cartledge Biomedical, Llc Rapid infusion system
US20040024380A1 (en) * 2002-08-05 2004-02-05 Darnell Lawrence W. Container for delivery of fluid to ophthalmic surgical handpiece
US20040210281A1 (en) * 2003-03-17 2004-10-21 Elizabeth Dzeng Transesophageal heat exchange catheter for cooling of the heart
US7303328B2 (en) * 2003-05-20 2007-12-04 C.R.F. Societa Consortile Per Azioni Disposable cartridge for mixing exothermic or endothermic reaction substances, and relative cartridge-support assembly
US20080027383A1 (en) * 2006-07-26 2008-01-31 Fathallah Nahhas Cooling apparatus and method for reducing risk of male infertility in heated environments
US7422600B2 (en) * 1999-02-09 2008-09-09 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing administration of anti-shivering agents
US7449018B2 (en) * 1998-03-31 2008-11-11 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon
US20080319403A1 (en) * 2004-06-22 2008-12-25 Boston Scientific Scimed, Inc. Medical device including actuator
US7806915B2 (en) * 2005-04-27 2010-10-05 Zoll Circulation, Inc. Apparatus and method for providing enhanced heat transfer from a body
US20110082423A1 (en) * 2009-10-06 2011-04-07 Serena Joshi Non-electric fluid heating component for use with fluid dispenser
US8157794B2 (en) * 1998-03-31 2012-04-17 Innercool Therapies, Inc. Method and device for performing cooling-or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
US8308787B2 (en) * 2008-01-25 2012-11-13 Neurosave, Inc. Rapid cooling of body and/or brain by irrigating with a cooling liquid
US8388571B2 (en) * 2009-10-06 2013-03-05 Bioquiddity, Inc. Fluid dispenser with non-electric fluid heating component
US8608696B1 (en) * 2009-02-24 2013-12-17 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids

Family Cites Families (181)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1189434B (en) 1982-12-07 1988-02-04 Grog Srl DISPOSABLE DEVICE FOR SELF-HEATING OR SELF-COOLING OF BEVERAGES AND FOODS THROUGH AN EXOTHERMAL OR ENDOTHERMAL REACTION
SE456274B (en) 1984-02-03 1988-09-19 Carl Gustaf Mellsjo DEVICE EXCHANGER TO GIVE ONE MEDIUM A SCRUBLIC CIRCULAR MOVEMENT
US4522640A (en) 1984-04-10 1985-06-11 Jagoe Iii A Louis Means for chilling cardioplegic solutions
US4705505A (en) 1984-09-28 1987-11-10 Fried Steven J Rapid solution administration set with integral heat exchanger
JPS6273062A (en) 1985-09-25 1987-04-03 右近 村次郎 Can in which drinking water or food is self-heated or self-cooled by exothermic or endothermic reaction
US4758562A (en) 1985-12-18 1988-07-19 Temple University Of The Commonwealth System Of Higher Education Method for inducing hypothermia and/or poikilothermia
CA1338485C (en) 1989-06-07 1996-07-30 Kenneth Kirk Isothermal cooling method and device
US4993237A (en) 1989-09-21 1991-02-19 Heritage Ventures U.S., Ltd. Self-cooling containers
JP2596169B2 (en) 1990-04-12 1997-04-02 松下電器産業株式会社 Cooler
US5624392A (en) 1990-05-11 1997-04-29 Saab; Mark A. Heat transfer catheters and methods of making and using same
IT1245824B (en) 1990-11-13 1994-10-24 Mi Go S R L Portable pack, capable of providing an instant source of cold by an endothermic chemical reaction
US5062269A (en) 1991-02-19 1991-11-05 Israel Siegel Disposable body cooler
US5263929A (en) 1991-08-28 1993-11-23 Normothermic Technologies, Inc. Portable fluid administration container with integral heat exchanger
US6110168A (en) 1993-02-10 2000-08-29 Radiant Medical, Inc. Method and apparatus for controlling a patient's body temperature by in situ blood temperature modifications
US6620188B1 (en) 1998-08-24 2003-09-16 Radiant Medical, Inc. Methods and apparatus for regional and whole body temperature modification
US6033383A (en) 1996-12-19 2000-03-07 Ginsburg; Robert Temperature regulating catheter and methods
US6849083B2 (en) 1993-02-10 2005-02-01 Radiant Medical, Inc. Method and apparatus for controlling a patients's body temperature by in situ blood temperature modification
US5837003A (en) 1993-02-10 1998-11-17 Radiant Medical, Inc. Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification
US6090132A (en) 1996-08-15 2000-07-18 Fox; James Allan Method and apparatus for inducing hypothermia
DE19653991A1 (en) 1996-12-21 1998-06-25 Degussa Reactor for carrying out endothermic catalytic reactions
WO1999023990A1 (en) 1997-11-07 1999-05-20 Hill-Rom, Inc. Medical equipment controller
US6076597A (en) 1997-12-31 2000-06-20 Flowserve Management Company Helical coil heat exchanger with removable end plates
US6096068A (en) 1998-01-23 2000-08-01 Innercool Therapies, Inc. Selective organ cooling catheter and method of using the same
US6379378B1 (en) 2000-03-03 2002-04-30 Innercool Therapies, Inc. Lumen design for catheter
US6843800B1 (en) 1998-01-23 2005-01-18 Innercool Therapies, Inc. Patient temperature regulation method and apparatus
US6051019A (en) 1998-01-23 2000-04-18 Del Mar Medical Technologies, Inc. Selective organ hypothermia method and apparatus
US7371254B2 (en) 1998-01-23 2008-05-13 Innercool Therapies, Inc. Medical procedure
US6719779B2 (en) 2000-11-07 2004-04-13 Innercool Therapies, Inc. Circulation set for temperature-controlled catheter and method of using the same
US7458984B2 (en) 1998-01-23 2008-12-02 Innercool Therapies, Inc. System and method for inducing hypothermia with active patient temperature control employing catheter-mounted temperature sensor and temperature projection algorithm
US6251130B1 (en) 1998-03-24 2001-06-26 Innercool Therapies, Inc. Device for applications of selective organ cooling
US6325818B1 (en) 1999-10-07 2001-12-04 Innercool Therapies, Inc. Inflatable cooling apparatus for selective organ hypothermia
US6383210B1 (en) 2000-06-02 2002-05-07 Innercool Therapies, Inc. Method for determining the effective thermal mass of a body or organ using cooling catheter
US6312452B1 (en) 1998-01-23 2001-11-06 Innercool Therapies, Inc. Selective organ cooling catheter with guidewire apparatus and temperature-monitoring device
US6558412B2 (en) 1998-01-23 2003-05-06 Innercool Therapies, Inc. Selective organ hypothermia method and apparatus
US6491039B1 (en) 1998-01-23 2002-12-10 Innercool Therapies, Inc. Medical procedure
US6149624A (en) 1998-02-05 2000-11-21 Mcshane; Richard Houston Apparatus and method for the rapid induction of hypothermic brain preservation
US6042559A (en) 1998-02-24 2000-03-28 Innercool Therapies, Inc. Insulated catheter for selective organ perfusion
US6736790B2 (en) 1998-02-25 2004-05-18 Denise R. Barbut Method and system for selective or isolated integrate cerebral perfusion and cooling
US6035102A (en) 1998-02-27 2000-03-07 Bakke; Allan P. Cylindrical electric liquid warming system utilizing heating by condensation
US6224624B1 (en) 1998-03-24 2001-05-01 Innercool Therapies, Inc. Selective organ cooling apparatus and method
US6551349B2 (en) 1998-03-24 2003-04-22 Innercool Therapies, Inc. Selective organ cooling apparatus
US6599312B2 (en) 1998-03-24 2003-07-29 Innercool Therapies, Inc. Isolated selective organ cooling apparatus
US7287398B2 (en) 2001-09-25 2007-10-30 Alsius Corporation Heating/cooling system for indwelling heat exchange catheter
US20030060761A1 (en) 1998-04-21 2003-03-27 Evans Scott M. Kit of parts including a heat exchange catheter for treating heart malady
US8128595B2 (en) 1998-04-21 2012-03-06 Zoll Circulation, Inc. Method for a central venous line catheter having a temperature control system
US6458150B1 (en) 1999-02-19 2002-10-01 Alsius Corporation Method and apparatus for patient temperature control
US6682551B1 (en) 1999-03-11 2004-01-27 Alsius Corporation Method and system for treating cardiac arrest using hypothermia
US6419643B1 (en) 1998-04-21 2002-07-16 Alsius Corporation Central venous catheter with heat exchange properties
US6126684A (en) 1998-04-21 2000-10-03 The Regents Of The University Of California Indwelling heat exchange catheter and method of using same
US6520933B1 (en) 1998-04-21 2003-02-18 Alsius Corporation Central venous line cooling catheter having a spiral-shaped heat exchange member
US6149670A (en) 1999-03-11 2000-11-21 Alsius Corporation Method and system for treating cardiac arrest using hypothermia
US6338727B1 (en) 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6450990B1 (en) 1998-08-13 2002-09-17 Alsius Corporation Catheter with multiple heating/cooling fibers employing fiber spreading features
US6620189B1 (en) 2000-02-28 2003-09-16 Radiant Medical, Inc. Method and system for control of a patient's body temperature by way of a transluminally insertable heat exchange catheter
US6428563B1 (en) 2000-01-21 2002-08-06 Radiant Medical, Inc. Heat exchange catheter with improved insulated region
US6610083B2 (en) 1998-08-24 2003-08-26 Radiant Medical, Inc. Multiple lumen heat exchange catheters
US20020161351A1 (en) 1998-09-01 2002-10-31 Samson Wilfred J. Method and apparatus for treating acute myocardial infarction with selective hypothermic perfusion
US20050004503A1 (en) 1998-09-01 2005-01-06 Samson Wilfred J. Method and apparatus for treating acute myocardial infarction with hypothermic perfusion
US20050080374A1 (en) 1998-09-01 2005-04-14 Brady Esch Method and apparatus for treating acute myocardial infarction with selective hypothermic perfusion
US6146411A (en) 1998-12-24 2000-11-14 Alsius Corporation Cooling system for indwelling heat exchange catheter
US6830581B2 (en) 1999-02-09 2004-12-14 Innercool Therspies, Inc. Method and device for patient temperature control employing optimized rewarming
EP1205167B1 (en) 1999-02-19 2006-10-11 Alsius Corporation Central venous line catheter having temperature control system
US6299599B1 (en) 1999-02-19 2001-10-09 Alsius Corporation Dual balloon central venous line catheter temperature control system
US6405080B1 (en) 1999-03-11 2002-06-11 Alsius Corporation Method and system for treating cardiac arrest
US6217552B1 (en) 1999-03-01 2001-04-17 Coaxia, Inc. Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma
US6019783A (en) 1999-03-02 2000-02-01 Alsius Corporation Cooling system for therapeutic catheter
US6233945B1 (en) 1999-03-06 2001-05-22 Allegiance Corporation Extended life cold pack
US6460544B1 (en) 1999-03-11 2002-10-08 Alsius Corporation Method and apparatus for establishing and maintaining therapeutic hypothemia
US6290717B1 (en) 1999-03-31 2001-09-18 Alsius Corporation Temperature probe and interconnect cable for hypothermia catheter temperature feedback
US6547811B1 (en) 1999-08-02 2003-04-15 Arch Development Corporation Method for inducing hypothermia
US7422601B2 (en) 1999-08-02 2008-09-09 University Of Chicago Office Of Technology Transfer Method for inducing hypothermia
US6962601B2 (en) 1999-08-02 2005-11-08 University Of Chicago Office Of Technology Transfer Method for inducing hypothermia
US6231594B1 (en) 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
US6726710B2 (en) 1999-08-16 2004-04-27 Alsius Corporation Method and system for treating cardiac arrest using hypothermia
US6264679B1 (en) 1999-08-20 2001-07-24 Radiant Medical, Inc. Heat exchange catheter with discrete heat exchange elements
US6530894B1 (en) 1999-11-16 2003-03-11 Coaxia, Inc. Aortic shunt with spinal perfusion and cooling device
WO2001041708A2 (en) 1999-12-07 2001-06-14 Alsius Corporation Method and system for treating stroke using hypothermia
WO2001043661A2 (en) 1999-12-14 2001-06-21 Radiant Medical, Inc. Method for reducing myocardial infarct by applicaton of intravascular hypothermia
WO2001058397A1 (en) 2000-02-09 2001-08-16 Radiant Medical, Inc. Multiple lumen heat exchange catheters
WO2003066137A1 (en) 2002-02-05 2003-08-14 Argmed Kb Cerebral temperature control
SE0002100D0 (en) 2000-06-05 2000-06-05 Jostra Ab Cerebral tempering
US6726708B2 (en) 2000-06-14 2004-04-27 Innercool Therapies, Inc. Therapeutic heating and cooling via temperature management of a colon-inserted balloon
AU2007201161B2 (en) 2000-07-21 2010-12-16 Zoll Circulation, Inc. Heat exchanger catheter for controlling body temperature
WO2002026175A1 (en) 2000-09-28 2002-04-04 Alsius Corporation Venous line catheter and method of operating the same
WO2002028458A1 (en) 2000-10-06 2002-04-11 Maxwell Edmund Whisson Body heat actuated parenteral device
US6719723B2 (en) 2000-12-06 2004-04-13 Innercool Therapies, Inc. Multipurpose catheter assembly
IT1319549B1 (en) 2000-12-14 2003-10-20 Methanol Casale Sa REACTOR FOR THE PERFORMANCE OF EXOTHERMAL OR ENDOTHERMAL HETEROGENEOUS REACTIONS
WO2002058606A1 (en) 2001-01-24 2002-08-01 Alsius Corporation Central venous catheter with heat exchange properties
US6582457B2 (en) 2001-02-15 2003-06-24 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
US6544282B1 (en) 2001-02-21 2003-04-08 Radiant Medical, Inc. Inhibition of platelet activation, aggregation and/or adhesion by hypothermia
US6451045B1 (en) 2001-02-22 2002-09-17 Alsius Corporation Heat exchange catheter having a helically wrapped heat exchanger
US6709448B2 (en) 2001-04-13 2004-03-23 Alsius Corporation Open core heat exchange catheter, system and method
US6641603B2 (en) 2001-04-13 2003-11-04 Alsius Corporation Heat exchange catheter having helically wound reinforcement
US6699269B2 (en) 2001-04-30 2004-03-02 Rohit K. Khanna Selective brain and spinal cord hypothermia method and apparatus
US8123789B2 (en) 2002-04-29 2012-02-28 Rohit Khanna Central nervous system cooling catheter
US6752786B2 (en) 2001-05-31 2004-06-22 Radiant Medical, Inc. Moving heat exchange catheter system
US6706060B2 (en) 2001-06-05 2004-03-16 Alsius Corporation Heat exchange catheter
US6679906B2 (en) 2001-07-13 2004-01-20 Radiant Medical, Inc. Catheter system with on-board temperature probe
US6623514B1 (en) 2001-08-01 2003-09-23 Origin Medsystems, Inc. Method of cooling an organ
JP2004538087A (en) 2001-08-15 2004-12-24 インナークール セラピーズ, インコーポレイテッド Patient temperature control system and method using temperature planning algorithm
US6607517B1 (en) 2001-08-24 2003-08-19 Radiant Medical, Inc. Method of inotropic treatment of heart disease using hypothermia
US7175655B1 (en) 2001-09-17 2007-02-13 Endovascular Technologies, Inc. Avoiding stress-induced martensitic transformation in nickel titanium alloys used in medical devices
US6800068B1 (en) 2001-10-26 2004-10-05 Radiant Medical, Inc. Intra-aortic balloon counterpulsation with concurrent hypothermia
US7144418B1 (en) 2001-11-02 2006-12-05 Medcool, Inc. Method, and system for selective cerebral hypothermia
US6572640B1 (en) 2001-11-21 2003-06-03 Alsius Corporation Method and apparatus for cardiopulmonary bypass patient temperature control
US7241307B2 (en) 2001-12-31 2007-07-10 Medcool, Inc. Method and apparatus for managing temperature in a patient
US7156867B2 (en) 2001-12-31 2007-01-02 Medcool, Inc. Uniform selective cerebral hypothermia
US7077825B1 (en) 2002-01-16 2006-07-18 Radiant Medical, Inc. Method for gastric cooling using balloon catheter
US20040158191A1 (en) 2002-03-19 2004-08-12 Samson Wilfred J. Method and apparatus for treating acute myocardial infarction with hypothermic perfusion
CN2538331Y (en) 2002-03-25 2003-03-05 中国人民解放军第一四一医院 Portable profound hypothermia blood constituent storing apparatus
US7052509B2 (en) 2002-04-29 2006-05-30 Medcool, Inc. Method and device for rapidly inducing and then maintaining hypothermia
US7008445B2 (en) 2002-04-29 2006-03-07 Medcool, Inc. Method and device for rapidly inducing hypothermia
EP1362537A1 (en) 2002-05-17 2003-11-19 Crown Cork & Seal Technologies Corporation Self heating or cooling container
US20030216746A1 (en) 2002-05-20 2003-11-20 Worthen William J. Method and system for treating stroke using hypothermia
US7666213B2 (en) 2002-07-11 2010-02-23 Life Recovery Systems Hd, Llc Apparatus for altering the body temperature of a patient
US6878156B1 (en) 2002-07-26 2005-04-12 Alsius Corporation Portable cooler for heat exchange catheter
AU2003270600B2 (en) 2002-09-12 2008-08-14 Radiant Medical, Inc. System and method for determining and controlling core body temperature
EP1431690A1 (en) 2002-12-18 2004-06-23 Dieau S.A. Fluid cooling system, cooled fluid dispenser comprising the latter, and methods for sterilization thereof
US7278984B2 (en) 2002-12-31 2007-10-09 Alsius Corporation System and method for controlling rate of heat exchange with patient
NZ523962A (en) 2003-01-31 2004-10-29 Energy Saving Concepts Ltd Heat exchanger with multiple turbulent flow paths
US20040199114A1 (en) 2003-04-01 2004-10-07 Alsius Corporation Intravascular heat exchange catheter with tissue preservative
US6893454B2 (en) 2003-04-28 2005-05-17 Alsius Corporation Intrarectal heat exchange catheter
US20040215163A1 (en) 2003-04-28 2004-10-28 Walker Blair D. Intravascular heat exchange catheter with multiple coolant inlet holes to balloon
US7001418B2 (en) 2003-04-30 2006-02-21 Alsius Corporation Intravascular heat exchange catheter with insulated coolant tubes
US7291127B2 (en) 2003-07-28 2007-11-06 Boston Scientific Scimed, Inc. Variable manipulative strength catheter
US20050033391A1 (en) 2003-08-06 2005-02-10 Alsius Corporation System and method for treating cardiac arrest and myocardial infarction
US7326195B2 (en) 2003-11-18 2008-02-05 Boston Scientific Scimed, Inc. Targeted cooling of tissue within a body
US20050120734A1 (en) 2003-12-04 2005-06-09 Innercool Therapies, Inc. Induction of hypothermia by infusion of saline slush
US8100123B2 (en) 2004-01-22 2012-01-24 Thermocure, Inc. Respiratory system for inducing therapeutic hypothermia
WO2005112843A1 (en) 2004-05-18 2005-12-01 Radiant Medical, Inc. Cooling device for use with heat-exchange catheter and method of use
US7231771B2 (en) 2004-05-26 2007-06-19 Ardiem Medical, Inc. Apparatus and method for inducing emergency hypothermia
US20060136023A1 (en) 2004-08-26 2006-06-22 Dobak John D Iii Method and apparatus for patient temperature control employing administration of anti-shivering agents
US20060064146A1 (en) 2004-09-17 2006-03-23 Collins Kenneth A Heating/cooling system for indwelling heat exchange catheter
US20060161232A1 (en) 2005-01-18 2006-07-20 Kasza, Oras and Son to The University of Chicago Phase-change particulate ice slurry coolant medical delivery tubing and insertion devices
US7789846B2 (en) 2005-01-25 2010-09-07 Thermopeutix, Inc. System and methods for selective thermal treatment
US7524329B2 (en) 2005-02-08 2009-04-28 Wilson-Cook Medical Inc. Self contracting stent
US20060175543A1 (en) 2005-02-08 2006-08-10 John Elefteriades Intra-thecal catheter and method for cooling the spinal cord
US7892269B2 (en) 2005-04-18 2011-02-22 Zoll Circulation, Inc. External heat exchange pad for patient
US20060293732A1 (en) 2005-06-27 2006-12-28 Collins Kenneth A Thermoelectric cooler (TEC) heat exchanger for intravascular heat exchange catheter
ES2670822T3 (en) 2005-06-29 2018-06-01 Zoll Circulation, Inc. Devices and systems for rapid endovascular cooling
US7181927B2 (en) 2005-07-01 2007-02-27 Alsius Corporation Primary heat exchanger for patient temperature control
EP1898850A4 (en) 2005-07-05 2010-11-10 Kci Licensing Inc Portable therapeutic cooling system
EP1968508B1 (en) 2005-12-22 2019-05-15 Hybernia Medical LLC Systems for intravascular cooling
EP2013558B1 (en) 2006-04-18 2015-06-17 Medivance Incorporated Apparatus and method for cooling liquid in intravascular cooling system
US7867266B2 (en) 2006-11-13 2011-01-11 Zoll Circulation, Inc. Temperature management system with assist mode for use with heart-lung machine
US7892270B2 (en) 2006-11-21 2011-02-22 Zoll Circulation Inc. Temperature management system and method for burn patients
JP2008154751A (en) 2006-12-22 2008-07-10 Osaka Industrial Promotion Organization Low-temperature treating device
US20080271476A1 (en) 2007-02-09 2008-11-06 Elias Langguth Endothermic beverage cooler
AU2008237177A1 (en) 2007-04-05 2008-10-16 Velomedix, Inc Automated therapy system and method
US20080296190A1 (en) 2007-05-30 2008-12-04 Marak Joseph J IV infusion bag carrier pack
ES2496171T3 (en) 2007-07-05 2014-09-18 Saudi Basic Industries Corporation Process to perform an endothermic reaction
JP5410423B2 (en) 2007-07-09 2014-02-05 ベロメディックス,インク Hypothermia apparatus and method
WO2009023797A1 (en) 2007-08-14 2009-02-19 Innercool Therapies, Inc. Methods and systems for inducing therapeutic hypothermia in a pre-hospital, field, or ambulance setting
JP2011502237A (en) 2007-10-19 2011-01-20 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア System and method for generation of two-phase coolant and determination of its cooling capacity
US8366758B2 (en) 2008-02-11 2013-02-05 The Regents Of The University Of California Hypothermia for improving rate of functional recovery following pelvic surgeries
US8091337B2 (en) 2008-02-29 2012-01-10 Corning Incorporated Exhaust treatment device having a reactive compound and conditioning the device via endothermic reaction
DE102008017344A1 (en) 2008-04-04 2009-10-08 Linde Aktiengesellschaft Process and reactor for carrying out exothermic and endothermic reactions
WO2009124552A2 (en) 2008-04-09 2009-10-15 Neurokey A/S Use of a combination of hypothermia inducing drugs
WO2009124553A2 (en) 2008-04-09 2009-10-15 Neurokey A/S Use of hypothermia inducing drugs
US7827005B2 (en) 2008-04-21 2010-11-02 Zoll Circulation, Inc. System and method for testing heat exchange system for heat exchange catheter
US8529612B2 (en) 2008-06-24 2013-09-10 Mayo Foundation For Medical Education And Research Gastroduodenal balloon tubes and methods for use in localized hypothermia
US20100104493A1 (en) 2008-10-23 2010-04-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Reactive composite material structures with endothermic reactants
WO2010054312A1 (en) 2008-11-07 2010-05-14 Velomedix, Inc. Devices and methods for monitoring core temperature and an intraperitoneal parameter
US20110029050A1 (en) 2008-11-18 2011-02-03 John Elefteriades Intra-ventricular brain cooling catheter
CA2750473A1 (en) 2009-02-06 2010-08-12 Velomedix, Inc. Method and apparatus for inducing therapeutic hypothermia
SI3092982T1 (en) 2009-02-26 2020-09-30 Advanced Cooling Therapy, Inc. Devices for controlling patient temperature
WO2010111778A1 (en) 2009-03-30 2010-10-07 Steve Andre Beaudin Apparatus. system and methods for extracorporeal blood processing for selectively cooling the brain relative to the body during hyperthermic treatment or to induce hypothermia of the brain
WO2010148372A1 (en) 2009-06-19 2010-12-23 Benechill Devices for cooling the nasal cavity
ES2746877T3 (en) 2009-09-16 2020-03-09 Univ Texas Modification of the temperature in the body of a mammal
TW201117787A (en) 2009-11-24 2011-06-01 Univ China Medical Tissue cooling device
US20120095537A1 (en) 2010-02-08 2012-04-19 Hall Gregory W Method and Apparatus for Inducing Therapeutic Hypothermia
EP2536343B1 (en) 2010-02-16 2022-11-23 The Johns Hopkins University Device for non-invasive anatomical and systemic cooling and neuroprotection
WO2011156565A1 (en) 2010-06-10 2011-12-15 North American Rescue, Llc Intravenous fluid heater
EP2587951B1 (en) 2010-06-29 2016-02-10 Renato Rozental Therapeutic brain cooling system and spinal cord cooling system
WO2012012740A1 (en) 2010-07-23 2012-01-26 Neurosave, Inc. Imaging of regional and global brain function, perfusion, edema and damage using thermal imaging during upper aerodigestive tract temperature modulation
US9180043B2 (en) 2010-11-15 2015-11-10 Focal Cool, Llc Apparatus for treatment of reperfusion injury
US20120172781A1 (en) 2011-01-03 2012-07-05 Yanming Wang Method of resuscitation
EP2514453B1 (en) 2011-04-19 2013-11-27 Matthias Roth Apparatus for controlling a body temperature
CN102309786B (en) 2011-07-21 2012-11-28 珠海成富医疗器材有限公司 System for filling fluid into rectum and reducing temperature of human body
KR102023650B1 (en) 2011-07-25 2019-09-20 네우로세이브, 인코포레이티드 Non-invasive systems, devices, and methods for selective brain cooling
US11253392B2 (en) 2011-09-28 2022-02-22 Zoll Circulation, Inc. Endovascular cooling catheter system which employs phase-changing heat exchange media

Patent Citations (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065235A (en) * 1976-06-01 1977-12-27 Tuthill Pump Company Gear pump
US4653577A (en) * 1986-01-23 1987-03-31 Shiley, Inc. Unitary heat exchanger and debubbler for a liquid
US5827222A (en) * 1990-10-10 1998-10-27 Life Resuscitation Technologies, Inc. Method of treating at least one of brain and associated nervous tissue injury
US5149321A (en) * 1990-10-10 1992-09-22 Klatz Ronald M Brain resuscitation device and method for performing the same
US5395314A (en) * 1990-10-10 1995-03-07 Life Resuscitation Technologies, Inc. Brain resuscitation and organ preservation device and method for performing the same
US5584804A (en) * 1990-10-10 1996-12-17 Life Resuscitation Technologies, Inc. Brain resuscitation and organ preservation device and method for performing the same
US5752929A (en) * 1990-10-10 1998-05-19 Life Resuscitation Technologies, Inc. Method of preserving organs other than the brain
US5913885A (en) * 1991-05-22 1999-06-22 Life Science Holdings, Inc. Brain cooling device and method for cooling
US5219274A (en) * 1992-08-10 1993-06-15 Tuthill Corporation Pump with internal pressure relief
US20020045852A1 (en) * 1992-08-13 2002-04-18 Saab Mark A. Method for changing the temperature of a selected body region
US5429762A (en) * 1993-01-28 1995-07-04 Japan Pionics Co., Ltd. Cooling agent
US5494416A (en) * 1993-11-12 1996-02-27 Tuthill Corporation Magnetically driven positive displacement pump and thrust bearing assembly
US5840068A (en) * 1996-02-28 1998-11-24 Cartledge; Richard G. Rapid infusion system
US5927273A (en) * 1996-03-08 1999-07-27 Life Resuscitation Technologies, Inc. Combined liquid ventilation and cardiopulmonary resuscitation method
US8157794B2 (en) * 1998-03-31 2012-04-17 Innercool Therapies, Inc. Method and device for performing cooling-or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation
US6231595B1 (en) * 1998-03-31 2001-05-15 Innercool Therapies, Inc. Circulating fluid hypothermia method and apparatus
US7449018B2 (en) * 1998-03-31 2008-11-11 Innercool Therapies, Inc. Method and device for performing cooling- or cryo-therapies for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing microporous balloon
US7422600B2 (en) * 1999-02-09 2008-09-09 Innercool Therapies, Inc. Method and apparatus for patient temperature control employing administration of anti-shivering agents
US6158994A (en) * 1999-04-21 2000-12-12 Tuthill Corporation Grooved rotor for an internal gear pump
US6554791B1 (en) * 1999-09-29 2003-04-29 Smisson-Cartledge Biomedical, Llc Rapid infusion system
US6270324B1 (en) * 1999-10-26 2001-08-07 Tuthill Corp. Positive displacement pump and thrust bearing assembly
US20040024380A1 (en) * 2002-08-05 2004-02-05 Darnell Lawrence W. Container for delivery of fluid to ophthalmic surgical handpiece
US20040210281A1 (en) * 2003-03-17 2004-10-21 Elizabeth Dzeng Transesophageal heat exchange catheter for cooling of the heart
US7758623B2 (en) * 2003-03-17 2010-07-20 The Board Of Trustees Of The Leland Stanford Junior University Transesophageal heat exchange catheter for cooling of the heart
US7303328B2 (en) * 2003-05-20 2007-12-04 C.R.F. Societa Consortile Per Azioni Disposable cartridge for mixing exothermic or endothermic reaction substances, and relative cartridge-support assembly
US20080319403A1 (en) * 2004-06-22 2008-12-25 Boston Scientific Scimed, Inc. Medical device including actuator
US7806915B2 (en) * 2005-04-27 2010-10-05 Zoll Circulation, Inc. Apparatus and method for providing enhanced heat transfer from a body
US20080027383A1 (en) * 2006-07-26 2008-01-31 Fathallah Nahhas Cooling apparatus and method for reducing risk of male infertility in heated environments
US8308787B2 (en) * 2008-01-25 2012-11-13 Neurosave, Inc. Rapid cooling of body and/or brain by irrigating with a cooling liquid
US8608696B1 (en) * 2009-02-24 2013-12-17 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
US8808241B2 (en) * 2009-02-24 2014-08-19 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
US20110082423A1 (en) * 2009-10-06 2011-04-07 Serena Joshi Non-electric fluid heating component for use with fluid dispenser
US8388578B2 (en) * 2009-10-06 2013-03-05 Bioquiddity, Inc. Non-electric fluid heating component for use with fluid dispenser
US8388571B2 (en) * 2009-10-06 2013-03-05 Bioquiddity, Inc. Fluid dispenser with non-electric fluid heating component

Also Published As

Publication number Publication date
US8808241B2 (en) 2014-08-19
US20140046257A1 (en) 2014-02-13
US8608696B1 (en) 2013-12-17

Similar Documents

Publication Publication Date Title
US8808241B2 (en) Rapid fluid cooling devices and methods for cooling fluids
US10744276B2 (en) Portable fluid warmer
EP2013558B1 (en) Apparatus and method for cooling liquid in intravascular cooling system
WO2016054165A1 (en) Fluid cooling devices, systems and methods for cooling fluids
US8388578B2 (en) Non-electric fluid heating component for use with fluid dispenser
US7241307B2 (en) Method and apparatus for managing temperature in a patient
US8388571B2 (en) Fluid dispenser with non-electric fluid heating component
US9642974B2 (en) Method and apparatus for warming intravenous fluids
CA2672834A1 (en) Device and method for producing therapeutic foam
US11903970B2 (en) Device and methods for platelet lysis or activation
WO2006056015A1 (en) Fluid warmer
AU2017371226B2 (en) Devices, systems, and methods for the embolization of body lumens
JP6707667B2 (en) Recirculation cooling system for use with energy delivery device
US20130298903A1 (en) Disposable thermal therapeutic apparatus and method of thermally controlling the delivery of medication therewith
CN104162213A (en) Quick fluid cooling device
WO2018119377A1 (en) Device and methods for platelet lysis or activation

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION